Hypertension as a Risk Factor for Contrast-Associated Acute Kidney Injury: A Meta-Analysis Including 2,830,338 Patients

• Published in: Kidney & blood pressure research 2021-12, Vol.46 (6), p.670-692
• Main Authors: Lun, Zhubin, Mai, Ziling, Liu, Liwei, Chen, Guanzhong, Li, Huanqiang, Ying, Ming, Wang, Bo, Chen, Shiqun, Yang, Yongquan, Liu, Jin, Chen, Jiyan, Ye, Jianfeng, Liu, Yong
• Format: Article
• Language: English
• Subjects: Acute coronary syndromes; Acute Kidney Injury - etiology; adjusted odds ratio; Contrast Media - adverse effects; contrast-associated acute kidney injury; Coronary Angiography - adverse effects; Creatinine; Heart attacks; Humans; Hypertension; Hypertension - complications; Incidence; Injury analysis; Kidneys; Literature reviews; Meta-Analysis; Observational studies; Patients; Quality assessment; Quality control; Risk Factors; Sensitivity analysis
• ISSN: 1420-4096; 1423-0143
• DOI: 10.1159/000517560

Objective: Previous studies have shown that the relationship between hypertension (HT) and contrast-associated acute kidney injury (CA-AKI) is not clear. We apply a systematic review and meta-analysis to assess the association between HT and CA-AKI. Methods: We searched for articles on the study of risk factors for CA-AKI in the Embase, Medline, and Cochrane Database of Systematic Reviews (by March 25, 2021). Two authors independently performed quality assessment and extracted data such as the studies’ clinical setting, the definition of CA-AKI, and the number of patients. The CA-AKI was defined as a serum creatinine (SCr) increase ≥25% or ≥0.5 mg/dL from baseline within 72 h. We used fixed or random models to pool adjusted OR (aOR) by STATA. Results: A total of 45 studies (2,830,338 patients) were identified, and the average incidence of CA-AKI was 6.48%. There was an increased risk of CA-AKI associated with HT (aOR: 1.378, 95% CI: 1.211–1.567, I 2 = 67.9%). In CA-AKI with a SCr increase ≥50% or ≥0.3 mg/dL from baseline within 72 h, an increased risk of CA-AKI was associated with HT (aOR: 1.414, 95% CI: 1.152–1.736, I 2 = 0%). In CA-AKI with a Scr increase ≥50% or ≥0.3 mg/dL from baseline within 7 days, HT increases the risk of CA-AKI (aOR: 1.317, 95% CI: 1.049–1.654, I 2 = 51.5%). Conclusion: Our meta-analysis confirmed that HT is an independent risk factor for CA-AKI and can be used to identify risk stratification. Physicians should pay more attention toward prevention and treatment of patients with HT in clinical practice.